-
Mashup Score: 1New FDA Orphan Drug Designation Issued: VGT-1849A for Polycythemia Vera | Docwire News - 8 hour(s) ago
This novel JAK2 inhibitor features reduced off-target suppression of JAK1, JAK3, TYK2, and other kinases.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
In reporting of new, upcoming agents on #Heme Today: @US_FDA has granted Orphan Drug Designation to the #JAK2inhibitor #VGT1849A for #polycythemiavera. https://t.co/2fVZPRRR2x